Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Symptom severity
[25] RCT 3-armed trial	65 people in whom GAD was the primary diagnosis	Change in Clinician Severity Rating 12 weeks From 5.36 to 2.55 with applied relaxation From 5.90 to 4.78 with waiting list control	P = 0.006	Effect size not calculated	applied relaxation
[25] RCT 3-armed trial	65 people in whom GAD was the primary diagnosis	Change in Penn State Worry Questionnaire score 12 weeks From 58.01 to 52.16 with applied relaxation From 57.34 to 58.80 with waiting list control	P value not reported Reported as not significant		Not significant
[25] RCT 3-armed trial	65 people in whom GAD was the primary diagnosis	Change in Worry and Anxiety Questionnaire, Somatic Scale 12 weeks From 20.82 to 17.91 with applied relaxation From 22.42 to 21.45 with waiting list control	P value not reported Reported as not significant		Not significant
[25] RCT 3-armed trial	65 people in whom GAD was the primary diagnosis	Change in State Trait Anxiety Inventory, trait version 12 weeks From 52.23 to 46.95 with applied relaxation From 52.06 to 48.98 with waiting list control	P value not reported Reported as not significant		Not significant